58
Participants
Start Date
January 1, 2022
Primary Completion Date
December 31, 2030
Study Completion Date
December 31, 2033
Magnetic resonance guided radiotherapy
Radical radiotherapy boosting for low rectal cancer through magnetic resonance guided radiotherapy linear accelerator.
Chemotherapy
"For patients with AJCC stage II and III and age \< 72 years old, Capox ×6→capecitabine×2.~Detailed usage: Oxaliplatin 130mg/m2 (reduced to 100mg/m2 during concurrent chemoradiotherapy), intravenous administration, d1. Capecitabine 1000mg / m2, twice a day, d1-14. Repeated every 3 weeks.~For patients aged ≥ 72 years, or the competent physician judges that the patients cannot tolerate dual drug combined chemotherapy, capecitabine ×8 courses.~For patients with AJCC stage I, capecitabine ×4 courses."
Sun Yat-sen University Cancer Center, Guangzhou
Sun Yat-sen University
OTHER